A landmark deal aims to end the pricing games that grossly inflate what you pay at the pharmacy.

The Federal Trade Commission has reached a landmark settlement with Express Scripts, banning practices that favored high-priced drugs for bigger rebates and requiring lower-cost options be included in ...

ST. LOUIS, Feb. 6, 2019 /PRNewswire/ -- Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across ...

ST. LOUIS--(BUSINESS WIRE)--May 6, 2003--The online customer experience that Express Scripts (Nasdaq: ESRX) provides its Web site visitors is the best of 38 leading healthcare organizations surveyed ...

The company that manages Tricare's pharmacy benefits will give thousands of independent and community pharmacies that left the network last month an opportunity to rejoin -- but it's unclear whether ...

Express Scripts is putting companies offering cutting-edge treatments into a "formulary" of recommendations for insurance plans and doctors. The hope is to make it easier for digital health companies ...

The MarketWatch News Department was not involved in the creation of this content. Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates ...

The nation's largest pharmacy benefits manager, Express Scripts Holding Company, issued a strong outlook for the second quarter in its earnings release. The company said it expects current-quarter ...

ST. LOUIS, May 7, 2020 /PRNewswire/ -- Express Scripts today announced a new program to ensure Americans can continue to afford their prescription medications during the COVID-19 pandemic. Any ...

Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...

The potential deal comes about a year and a half after the FTC first brought the case against Express Scripts, CVS’ Caremark and UnitedHealth’s Optum Rx. If approved, the agreement would mark the ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...